Phage Based Diagnostics

01359 231856

Twitter Youtube Linkedin Envelope
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us
Menu
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us
Search
Generic filters

Colorado Laboratory trials new Actiphage test to improve bovine TB diagnosis

The Animal Health Laboratory within the Colorado Department of Agriculture is assisting in a trial of Actiphage®, a new rapid blood test for bovine Tuberculosis (bTB) that will detect early-stage infection in cattle and other animals.
  • July 24, 2019
  • International
  • international
Colerado cows

bTB is a contagious and infectious disease caused by Mycobacterium bovis. It primarily affects cattle, but is known to infect bison, deer, elk, goats and other warm-blooded species. In very rare cases, the disease can also be transmitted to humans through direct contact with infected animals or consumption of raw milk.

The Animal Health Lab, an ISO 17025 accredited laboratory, aims to determine the accuracy of the new Actiphage test, particularly in detecting the disease at a very early stage, which will assist in the control of infection.

A large number of cattle enter the US from Mexico – some 1.5 million head per year – and traces of TB have been detected in this border region over the last 18 months. The pilot study will initially use Actiphage to test blood samples from cattle that have been highlighted as having a high risk of infection.

This trial will be an exploratory project under the Lab Manager, Ms. Tiffany Brigner, with a permit granted by the Center for Veterinary Biologics (CVB), an agency of the USDA.

Ms. Brigner explains, “The control of bTB is very important. Having an assay that can detect bTB quickly and accurately would aid in mitigating the spread of this contagious disease.”

Robert Lyons is Director of North America operations for PBD Biotech, the company that has developed Actiphage. He explains that the Colorado trial will provide important independent validation of the test, building on the test’s US patent which came into effect earlier this month.

Robert said: “Actiphage can be used to detect bTB and Johne’s disease in blood or milk samples and has been effectively used in bTB eradication strategies leading to its approval for exceptional private use in cattle in the UK under the Government’s Animal and Plant Health Agency protocol.

“A trial on this scale will help us to further improve the diagnostic and provide insights into the aetiology of the disease within large herds.”

It comes as Actiphage is awarded a patent by the United States Patent and Trademark Office (No. 10,344,339)

Actiphage offers vets, farmers, zoology and exotic species experts, food manufacturers and others a rapid tool for early detection of live bacteria, facilitating improved food safety as well as containment and control of disease.

For more information about other Actiphage trials and pilots, visit PBD Biotech’s Research page.

Share:

Related posts

Loading...
Tom Kellner

PBD Biotech expands its North American operations

January 27, 2022
PBD Biotech is expanding its North American team. Tuberculosis (TB) and Johne’s Disease expert Tom Kellner has been appointed as Director of Operations in North America, to advise on regulatory affairs and provide technical and customer support.
Tom Kellner

PBD Biotech expands its North American operations

January 27, 2022
PBD Biotech is expanding its North American team. Tuberculosis (TB) and Johne’s Disease expert Tom Kellner has been appointed as...
Luis Martin

Actiphage diagnostic for Johne’s Disease gains funding from Canadian Gov

June 9, 2020
Johne’s disease, a wasting condition of cattle, costs the Canadian dairy industry an estimated $90 million a year through loss of production. Now, advisory services and funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP)...
Luis Martin

Actiphage diagnostic for Johne’s Disease gains funding from Canadian Gov

June 9, 2020
Johne’s disease, a wasting condition of cattle, costs the Canadian dairy industry an estimated $90 million a year through loss...
Missouri

Bovine TB test developers selected for USA agri-food delegation

February 24, 2020
PBD Biotech, developers of a rapid new test for bovine TB, is one of seven UK agri-tech companies to have been selected to join the first Missouri Agri-Tech Connect Programme this week (23 – 27 February 2020).
Missouri

Bovine TB test developers selected for USA agri-food delegation

February 24, 2020
PBD Biotech, developers of a rapid new test for bovine TB, is one of seven UK agri-tech companies to have...
Fiji

27-28 November 2019

PBD Biotech invited to speak at Fiji Bovine TB Eradication Forum

November 7, 2019
Dr Ben Swift, co-founder of PBD Biotech, has been invited by Fiji’s Ministry of Agriculture to speak at its 2nd Bovine Brucellosis and Tuberculosis Eradication Campaign (BTEC) Forum on 27 and 28 November 2019.
Fiji

27-28 November 2019

PBD Biotech invited to speak at Fiji Bovine TB Eradication Forum

November 7, 2019
Dr Ben Swift, co-founder of PBD Biotech, has been invited by Fiji’s Ministry of Agriculture to speak at its 2nd...
1 2 Next »

developers of phage-based diagnostics

Contact Us

PBD Biotech Ltd
Link House, Elm Farm Park,
Great Green, Thurston,
Suffolk IP31 3SH,
United Kingdom

Registered Company Address
Ingenuity Centre,
University of Nottingham,
Innovation Park, Triumph Rd,
Nottingham NG7 2TU,
United Kingdom

T: 01359 231856
info@pbdbio.com

Privacy and cookies policy

© 2022 PBD Biotech Ltd

design: out of house

  • Follow Us!
PBD Biotech

If you are going @CheshireShow there is an opportunity to talk to @ZaraBewizibet senior scientific adviser to Defra TB Policy. She is on the Cheshire Badger Vaccination Project @CBVP2021 stand. Good to see some joined up thinking #BadgerTrust #EndTB

Read More
PBD Biotech

@PeterMullowney Thank you @PeterMullowney for a very productive conference with many inspiring presentations. So good to see everyone @paratb2022

Read More
PBD Biotech

@1GarethWynJones @downtoearthuk_ @clovermad Mum always knows best 😉 Well done @clovermad for hosting.

Read More